Business Context and Reporting Period
Company: Kewaunee Scientific Corporation (KEQU)
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three and nine months ended January 31, 2026 (Fiscal Year 2026 Q3).
Business Overview: The Company designs, manufactures, and installs scientific and technical furniture. Operations are classified into Domestic and International segments. A significant strategic development was the November 1, 2024, acquisition of Nu Aire, Inc., a manufacturer of biological safety cabinets and laboratory equipment, which is now integrated into the Domestic segment.
Key Financial Metrics
| Metric ($ in thousands) | 3 Months Ended Jan 31, 2026 | 9 Months Ended Jan 31, 2026 | 3 Months Ended Jan 31, 2025 | 9 Months Ended Jan 31, 2025 |
|---|---|---|---|---|
| Net Sales | $69,399 | $210,599 | $67,167 | $163,324 |
| Gross Profit | $18,545 | $59,195 | $18,379 | $44,819 |
| Gross Margin % | 26.7% | 28.1% | 27.4% | 27.4% |
| Operating Profit | $2,582 | $11,499 | $2,250 | $9,259 |
| Net Earnings (Total) | $1,076 | $6,773 | $1,383 | $6,636 |
| Net Earnings Attributable to Kewaunee | $692 | $6,230 | $1,354 | $6,555 |
| Diluted EPS (Attributable to Kewaunee) | $0.23 | $2.09 | $0.45 | $2.20 |
| Operating Cash Flow (9 Months) | $13,173 (2026) vs $5,376 (2025) | |||
| Cash & Equivalents (Jan 31, 2026) | $8,153 | |||
| Total Debt (Long-term + Current) | ~$26.8M (Excluding leases) |
Material Changes vs. Prior Period
- Revenue Growth: Nine-month net sales increased 29.0% to $210.6 million, driven primarily by the Nu Aire acquisition (Domestic sales up 29.6%) and a 27.0% increase in International sales due to higher billings in India.
- Profitability: While operating profit increased for the nine-month period, net earnings attributable to Kewaunee decreased 5.0% year-over-year ($6.23M vs $6.56M). This was due to higher non-controlling interest allocations ($543k vs $81k) and increased interest expense.
- Interest Expense: Interest expense rose significantly for the nine-month period to $3.23 million from $2.05 million, attributed to higher borrowing levels and interest rates associated with the Nu Aire acquisition financing.
- Debt Restructuring: The Company repaid $23.0 million in subordinated seller notes related to the Nu Aire acquisition in December 2025, funded by a new $10.0 million term loan and revolver draws.
- Backlog: Order backlog decreased to $183.2 million at January 31, 2026, from $221.6 million in the prior year period.
Guidance, Outlook, and Risks
- Outlook: Management notes that Q3 results align with expectations regarding volatility in project delivery and seasonal slowdowns in construction. The softness in the construction segment was offset by Nu Aire's end-user containment products.
- Tax Legislation: The Company evaluated the impact of the "One Big Beautiful Bill Act" (OBBBA) enacted July 4, 2025, which affected the effective tax rate and deferred tax balances due to bonus amortization acceleration.
- Risks: Key risks include dependence on laboratory construction projects, raw material cost fluctuations (steel, wood, epoxy), geopolitical uncertainty, and the ability to realize anticipated synergies from the Nu Aire acquisition.
- Liquidity: The Company maintains a $20.0 million revolving credit facility with PNC (unused as of period end) and believes current sources are sufficient for ongoing requirements.
Investor Verification Checklist
- Nu Aire Integration: Verify the realization of synergies and the specific contribution of Nu Aire to future margins, as operating expenses increased significantly post-acquisition.
- Debt Servicing: Monitor the impact of the new term loan structure and interest rate environment on future interest expense and cash flow.
- Construction Backlog: Track the order backlog trend, as it declined significantly year-over-year, indicating potential headwinds in the core construction segment.
- Non-Controlling Interest: Review the increasing allocation of net earnings to non-controlling interests, which reduced earnings attributable to common shareholders.
- International Exposure: Assess the sustainability of the 27% growth in International sales, particularly reliance on the Indian market.